Division of Pediatric Infectious Diseases, Allergy, and Rheumatology, University of Washington and Children's Hospital and Regional Medical Center, Seattle, Washington 98105, USA
Auto-generated profile, based on publicly available information
Janet A. Englund
Division of Pediatric Infectious Diseases, Allergy, and Rheumatology, University of Washington and Children's Hospital and Regional Medical Center, Seattle, Washington 98105, USA
Background. Trivalent inactivated influenza vaccine (TIV) is recommended for all children ages 6 to 23 months. Delivering 2 doses of TIV at least 4 weeks apart to young children receiving this vaccine for the first time is challenging.